DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Pacifico L, Bonci E, Di Martino M. , et al.
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
Nutr Metab Cardiovasc Dis 2015;
25 (08) 734-741
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.